Phase 2b Study to Evaluate the Efficacy and Safety of ISB 830 in Adults With Moderate to Severe Atopic Dermatitis
Clinical trial NCT03568162 · COMPLETED
Trial details
- NCT number
- NCT03568162
- Sponsor
- Ichnos Sciences SA
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-31
- Primary completion
- 2020-08-11
- Enrollment
- 462
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.